OpenAI acquired 4-year-old AI biotech startup Orchestra Bio on Tuesday to boost its Rosalind life sciences platform for AI-powered drug development.
Read MoreOpenAI acquired 4-year-old AI biotech startup Orchestra Bio on Tuesday to boost its Rosalind life sciences platform for AI-powered drug development.
Read More